Home » EMEA Announces Blueprint to Speed New Product Reviews
EMEA Announces Blueprint to Speed New Product Reviews
July 6, 2006
The European Medicines Agency (EMEA) has introduced new procedures designed to streamline the way the agency provides scientific advice on investigational medicines and help move them more quickly from the laboratory to the marketplace.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor